A major role for the minor capsid protein of human papillomavirus type 16 in immune escape.
about
Safety and Efficacy Data on Vaccines and Immunization to Human PapillomavirusImmunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells.Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosisEvasion of host immune defenses by human papillomavirusInhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppression.Keratinocyte antiviral response to Poly(dA:dT) stimulation and papillomavirus infection in a canine model of X-linked severe combined immunodeficiency.Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotype.Persistence of human papillomavirus infection: keys to malignant progressionDifferential expression of HPV16 L2 gene in cervical cancers harboring episomal HPV16 genomes: influence of synonymous and non-coding region variationsComparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years.Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:CHuman papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:C.Immunotherapy of human papilloma virus induced diseaseThe invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system.Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.L2, the minor capsid protein of papillomavirus.Treatment failure in patients with HPV 16-induced vulvar intraepithelial neoplasia: understanding different clinical responses to immunotherapy.Novel Approaches for Vaccination Against HPV-Induced Cancers.T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation.Functional analysis of HPV-like particle-activated Langerhans cells in vitro.Molecular analysis of human papillomavirus virus-like particle activated Langerhans cells in vitro.Host cell transcriptome modification upon exogenous HPV16 L2 protein expression.Modulation of antigen presenting cell functions during chronic HPV infection.Prognosis of HPV-positive head and neck cancers: implication of smoking and immunosuppression
P2860
Q26799574-E7DEC798-57A5-4C45-AFEA-FBA1F045B56CQ27307719-37BF487F-B298-4834-9750-79011F58B937Q27346336-F56AB037-D926-4A8A-AAFE-13F1C9684273Q28076194-26A64874-9C50-46EE-B8F5-6488EE59586EQ33604135-CBFC527D-B696-4756-B190-5FD3A19188BCQ33904660-C5248B0A-575A-4B68-ACBF-63531C2277C3Q34408919-BDEDBF76-F0D4-43BB-8F50-27B64E977C6AQ34690139-10759E6F-5007-41BF-AB0F-6F0D2A62C600Q34770066-CD8F423C-AF10-40B9-8F19-1E9D149D0088Q35918838-9BD82D27-6E39-4BD4-B82C-204EBAB148BBQ36315857-FCBDECF0-CF20-452C-903A-9B1A0209E713Q36350381-7BF87B10-CB52-42F7-A3DB-B02CF107B6EEQ36541008-B414FB4E-7DB4-405C-AFC7-263B120E4AB8Q36541450-766EDB7A-1250-49BD-B8C5-BA1E0DD48574Q37135023-F38792A3-233A-488B-B729-AB5D089179BCQ37164879-CCDB6BF4-A468-4FD6-BDC7-28EF38D45150Q38036688-0AC0FF2B-012C-4571-92DD-868B817B8947Q39033362-53B81725-B7C7-4126-BA5B-26BDB54334F5Q40673637-79A690DF-81A1-4615-A0BF-F8CFCBCA690DQ42182816-658AAB90-5A08-4439-970F-E137B2757945Q42182822-2E41F8BC-BB48-4639-91CF-C0E1ABE8513FQ45943269-434B6113-416F-4DCA-9089-E1D4478563A8Q49591682-6852B52D-6E5E-436E-A286-D4A38E94C7FFQ58127069-2F016F52-8205-4B19-9402-DEE8469C5ED2
P2860
A major role for the minor capsid protein of human papillomavirus type 16 in immune escape.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A major role for the minor cap ...... irus type 16 in immune escape.
@ast
A major role for the minor cap ...... irus type 16 in immune escape.
@en
type
label
A major role for the minor cap ...... irus type 16 in immune escape.
@ast
A major role for the minor cap ...... irus type 16 in immune escape.
@en
prefLabel
A major role for the minor cap ...... irus type 16 in immune escape.
@ast
A major role for the minor cap ...... irus type 16 in immune escape.
@en
P2093
P356
P1476
A major role for the minor cap ...... irus type 16 in immune escape.
@en
P2093
Adam B Raff
Diane M Da Silva
Laura M Fahey
W Martin Kast
P304
P356
10.4049/JIMMUNOL.0902145
P407
P577
2009-10-28T00:00:00Z